The skin is the most common target of graft-versus-host disease (GVHD), a frequent complication that occurs after a transplant using donor cells. Although most skin changes after transplant are mild or moderate, more severe skin problems are possible.

The way we think and process information can change after transplant, at least in the short-term time. Called cognitive problems, paying attention, concentrating, remembering things and learning new skills can be difficult. This presentation discusses the factors that can cause cognitive problems and strategies to manage them.

Stem cell transplants in older patients have, historically, had lower success rates than those in younger patients. This presentation describes several new promising strategies to improve transplant outcomes and survival rates in older patients. Many thanks to Pharmacyclics, an AbbVie Company, and Janssen Biotech, Inc., Jazz Pharmaceuticals and Omeros Corporation, whose support, in part helped make this workshop possible.

COVID-19 can cause serious illness and death. This presentation discusses the the most effective strategies to prevent a COVID infection, and the pros and cons of medications available to treat transplant recipients who do become infected. Many thanks to Takeda Pharmaceutical Company whose support, in part, made this workshop possible.

Transplant does not take away a woman’s sexuality but it can cause sexual difficulties after transplant. There are a variety of effective treatments. Good communication between partners is one important ingredient in resolving sexual difficulties after transplant.

Stem cell transplant recipients have an increased risk of developing sexual problems and infertility after transplant. In men, erectile dysfunction and low testosterone are the most common sexual problems reported, and both are very treatable.

Half of patients who have a stem cell transplant using donor cells (an allogeneic transplant) develop chronic graft-versus-host-disease (GVHD). In up to a third of those patients, GVHD affects the mouth, esophagus, stomach and/or GI tract. GVHD can also affect the liver and/or pancreas. This presentation describes the symptoms and treatment options for GI and liver GVHD.

Caregivers for stem cell transplant recipients deal with a lot of responsibility and uncertainty. Many find their role very stressful and burnout is common. Practicing self-care helps caregivers maintain both their physical and emotional health. Many thanks to Takeda Pharmaceutical Company whose support, in part, made this presentation possible.

Ocular graft-versus-host-disease occurs in 40% to 60% of allogeneic transplant patients. Early detection and treatment are important. This presentation reviews the most common symptoms and effective remedies for ocular GVHD.

Stem cell transplant patients have an increased risk of heart and vascular problems after transplant. The risk of cardiovascular complications increases over time after transplant. This presentation reviews the major cardiovascular complications, their underlying causes, and the most effective preventative measures and treatment options for addressing them.